Mesenbio
3 known investors
Find your way into Mesenbio
Sign up to see every warm intro you have to Mesenbio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Mesenbio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Mesenbio develops extracellular vesicle (EV) therapeutics derived from mesenchymal stem cells, using its FT-01 platform to enable scalable, GMP-ready EV manufacturing for regenerative medicine. The company is advancing a licensing-ready production platform and preclinical therapeutic candidate (MEV-N01) targeting rheumatoid arthritis.
Founders & leadership
DD

Dr. David KuntinChief Executive Officer
AA

Anita AdamsFinance DirectorAnita Adams is a fractional Finance Director with over 30 years of accounting experience, including 25 years in senior and executive roles, specializing in fund-raising, financial restructuring, and high-growth businesses.
Board
DD

Dr. David SimpsonChair
JG

Jason GoldsteinBoard director
Investors · 3
DSW Ventureslisted by DSW VenturesManchester · $130K – $1.3M
How we know: DSW Ventures's portfolio page · funding news · setsquared.co.uk · Not right? Tell us
Innovate UKreportedLondon
How we know: funding news · Not right? Tell us
Also in the syndicate · 1
NG Bio
In the news
Frequently asked questions
- What does Mesenbio do?
- Mesenbio develops extracellular vesicle (EV) therapeutics derived from mesenchymal stem cells, using its FT-01 platform to enable scalable, GMP-ready EV manufacturing for regenerative medicine. The company is advancing a licensing-ready production platform and preclinical therapeutic candidate (MEV-N01) targeting rheumatoid arthritis.
- Who are Mesenbio's investors?
- Mesenbio's investors include DSW Ventures, Innovate UK.
